Concurrent Inhibition of ERK and Farnesyltransferase Suppresses the Growth of HRAS Mutant Head and Neck Squamous Cell Carcinoma
Sehrish Javaid(University of North Carolina at Chapel Hill), Adrienne D. Cox(University of North Carolina at Chapel Hill), Frances L. Massey(University of North Carolina at Chapel Hill), Emanuel F. Petricoin(Center for Biologics Evaluation and Research), Kathryn N. Lambert(University of North Carolina at Chapel Hill), Andrew M. Waters(University of North Carolina at Chapel Hill), Victoria V. Nguyen(University of North Carolina at Chapel Hill), Antje Schaefer(University of North Carolina at Chapel Hill), Kris C. Wood(Duke University), Craig M. Goodwin(University of North Carolina at Chapel Hill), Channing J. Der(University of North Carolina at Chapel Hill), G. Aaron Hobbs(Medical University of South Carolina), Mariaelena Pierobon(George Mason University), J. Nathaniel Diehl(University of North Carolina at Chapel Hill), Da'Jhnae Gambrell-Sanders(University of North Carolina at Chapel Hill)
Cited by 18
Related Papers
Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation
|Journal of Clinical Investigation|2014|717
Rho-family GTPases: it's not only Rac and Rho (and I like it)
|Journal of Cell Science|2004|594